Project Type
independent
Project Start Date
09/30/2012
Project End Date
10/01/2017

This study is investigating whether treatment with Sumatriptan is effective in treating post-traumatic headache pain in people who have had a mild, moderate or severe TBI. Sumatriptan has been FDA approved since 1991 and can be prescribed to treat migraine headache in the general population. This study will also look at the viability of using an online headache tracker with the TBI population.